Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. market cap "Mid $2–10B"、profit streak "Full 10 yr"、No report yetで絞り込み：378 match(絞り込みを解除) · 4 ページ中 1 ページ。

#	銘柄	Mkt Cap	Score▼	Baillie	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	レポート	FY
1	Rightmove PLC RMV · LSE	$4.4B	94/100 卓越	—	60.0%low 60.0%	10 yr+	Net cash	100%	—	FY2025
2	Nemetschek AG O.N. NEM · XETRA	$7.2B	93/100 卓越	—	26.3%low 19.4%	10 yr+	0.2×	53%	—	FY2025
3	MarketAxess Holdings Inc MKTX · 米国株	$5.7B	93/100 卓越	—	25.1%low 19.7%	10 yr+	Net cash	77%	—	FY2025
4	Shenzhen New Industries Biomedical 300832 · 深圳	$5.3B	93/100 卓越	—	23.5%low 17.4%	10 yr+	Net cash	75%	—	FY2025
5	Proya Cosmetics Co Ltd Class A 603605 · 上海	$3.3B	93/100 卓越	—	22.1%low 13.8%	10 yr+	Net cash	66%	—	FY2025
6	Genpact Limited G · 米国株	$5.1B	92/100 卓越	—	20.4%low 16.8%	10 yr+	0.2×	36%	—	FY2025
7	Zhejiang Weixing New Building Materials Co Ltd 002372 · 深圳	$2.0B	92/100 卓越	—	23.9%low 15.2%	10 yr+	Net cash	43%	—	FY2025
8	Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · 上海	$5.0B	91/100 卓越	—	19.7%low 15.7%	10 yr+	Net cash	74%	—	FY2025
9	Hubei Jumpcan Pharmaceutical Co Ltd 600566 · 上海	$3.4B	91/100 卓越	—	21.6%low 12.2%	10 yr+	Net cash	83%	—	FY2025
10	IMI PLC IMI · LSE	$8.8B	90/100 卓越	—	24.4%low 21.3%	10 yr+	0.5×	45%	—	FY2025
11	Chemed Corp CHE · 米国株	$7.1B	90/100 卓越	—	29.2%low 18.2%	10 yr+	0.1×	33%	—	FY2025
12	Howden Joinery Group Plc HWDN · LSE	$5.5B	90/100 卓越	—	32.1%low 20.5%	10 yr+	0.3×	62%	—	FY2025
13	Ninety One PLC N91 · LSE	$2.7B	90/100 卓越	—	51.3%low 21.9%	10 yr+	Net cash	64%	—	FY2026
14	Hangzhou Robam Appliances Co Ltd 002508 · 深圳	$2.1B	90/100 卓越	—	19.8%low 10.9%	10 yr+	Net cash	53%	—	FY2025
15	Yealink Network Technology Corp Ltd 300628 · 深圳	$6.9B	89/100 卓越	—	28.7%low 20.6%	10 yr+	Net cash	67%	—	FY2025
16	MSC Industrial Direct Company Inc MSM · 米国株	$6.9B	89/100 卓越	—	20.2%low 14.4%	10 yr+	0.3×	42%	—	FY2025
17	Gentex Corporation GNTX · 米国株	$5.0B	89/100 卓越	—	18.6%low 15.4%	10 yr+	Net cash	36%	—	FY2025
18	Grand Canyon Education Inc LOPE · 米国株	$3.8B	89/100 卓越	—	23.3%low 16.3%	10 yr+	Net cash	52%	—	FY2025
19	Anhui Gujing Distillery Co Ltd 000596 · 深圳	$7.0B	88/100 卓越	—	18.6%low 13.9%	10 yr+	Net cash	77%	—	FY2025
20	Computacenter PLC CCC · LSE	$6.1B	88/100 卓越	—	20.0%low 14.9%	10 yr+	Net cash	14%	—	FY2025
21	Qualys Inc QLYS · 米国株	$5.1B	88/100 卓越	—	24.2%low 7.4%	10 yr+	Net cash	79%	—	FY2025
22	Rotork PLC ROR · LSE	$5.0B	88/100 卓越	—	16.4%low 12.2%	10 yr+	Net cash	46%	—	FY2025
23	Cohen & Steers Inc CNS · 米国株	$4.2B	88/100 卓越	—	40.2%low 27.3%	10 yr+	Net cash	50%	—	FY2025
24	Toro Co TTC · 米国株	$8.7B	87/100 卓越	—	32.6%low 21.8%	10 yr+	0.5×	35%	—	FY2025
25	Brady Corporation BRC · 米国株	$4.5B	87/100 卓越	—	14.9%low 12.1%	10 yr+	Net cash	50%	—	FY2025
26	Anhui Yingjia Distillery Co Ltd 603198 · 上海	$4.4B	87/100 卓越	—	21.0%low 16.2%	10 yr+	Net cash	66%	—	FY2025
27	HLA GROUP CORP LTD 600398 · 上海	$4.2B	87/100 卓越	—	19.8%low 11.8%	10 yr+	Net cash	39%	—	FY2025
28	Plus500 Ltd PLUS · LSE	$3.3B	87/100 卓越	—	52.0%low 38.8%	10 yr+	Net cash	100%	—	FY2025
29	Indutrade AB INDT · ST	$9.3B	86/100 卓越	—	19.6%low 15.0%	10 yr+	0.4×	34%	—	FY2025
30	Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · 上海	$6.8B	86/100 卓越	—	21.0%low 12.8%	10 yr+	Net cash	48%	—	FY2025
31	Zhejiang Supor Co Ltd 002032 · 深圳	$4.8B	86/100 卓越	—	28.8%low 23.7%	10 yr+	Net cash	26%	—	FY2025
32	RS GROUP PLC RS1 · LSE	$4.3B	86/100 卓越	—	19.3%low 11.3%	10 yr+	0.2×	43%	—	FY2026
33	Livzon Pharmaceutical Group Inc 000513 · 深圳	$3.9B	86/100 卓越	—	16.0%low 10.2%	10 yr+	Net cash	63%	—	FY2025
34	YETI Holdings Inc YETI · 米国株	$3.7B	86/100 卓越	—	35.8%low 17.0%	10 yr+	0.1×	53%	—	FY2025
35	Shanghai M&G Stationery Inc 603899 · 上海	$3.0B	86/100 卓越	—	20.8%low 14.1%	10 yr+	Net cash	23%	—	FY2025
36	Buckle Inc BKE · 米国株	$2.3B	86/100 卓越	—	39.8%low 22.8%	10 yr+	0.3×	46%	—	FY2026
37	IG Group Holdings PLC IGG · LSE	$6.1B	85/100 卓越	—	22.8%low 16.3%	10 yr+	Net cash	90%	—	FY2025
38	Vontier Corp VNT · 米国株	$4.5B	85/100 卓越	—	40.2%low 21.4%	10 yr+	1.3×	45%	—	FY2025
39	Acuity Brands Inc AYI · 米国株	$9.8B	84/100 卓越	—	17.1%low 11.7%	10 yr+	0.2×	43%	—	FY2025
40	Elisa Oyj ELISA · HE	$6.1B	84/100 卓越	—	28.4%low 26.4%	10 yr+	1.2×	62%	—	FY2025
41	Fuchs Petrolub SE Preference Shares FPE3 · XETRA	$5.7B	84/100 卓越	—	16.6%low 13.9%	10 yr+	Net cash	34%	—	FY2025
42	G-bits Network Technology Xiamen Co Ltd 603444 · 上海	$3.9B	84/100 卓越	—	28.1%low 19.3%	10 yr+	Net cash	90%	—	FY2025
43	Jiangzhong Pharmaceutical Co Ltd 600750 · 上海	$2.3B	84/100 卓越	—	15.8%low 12.2%	10 yr+	Net cash	66%	—	FY2025
44	Jafron Biomedical Co Ltd 300529 · 深圳	$2.1B	84/100 卓越	—	23.3%low 13.9%	10 yr+	Net cash	83%	—	FY2025
45	Huadong Medicine Co Ltd 000963 · 深圳	$7.1B	83/100 卓越	—	17.6%low 13.5%	10 yr+	Net cash	30%	—	FY2025
46	Morgan Sindall Group PLC MGNS · LSE	$2.6B	83/100 卓越	—	17.5%low 10.8%	10 yr+	Net cash	11%	—	FY2025
47	Landstar System Inc LSTR · 米国株	$5.9B	82/100 卓越	—	30.3%low 14.5%	10 yr+	Net cash	20%	—	FY2025
48	Trex Company Inc TREX · 米国株	$4.5B	82/100 卓越	—	33.1%low 18.4%	10 yr+	0.2×	40%	—	FY2025
49	Chongqing Brewery Co Ltd 600132 · 上海	$3.1B	82/100 卓越	—	49.8%low 14.7%	10 yr+	Net cash	46%	—	FY2025
50	Dashenlin Pharm Grp Co Ltd 603233 · 上海	$3.0B	82/100 卓越	—	18.2%low 13.3%	10 yr+	0.0×	38%	—	FY2025
51	CSG Systems International Inc CSGS · 米国株	$2.3B	82/100 卓越	—	20.0%low 12.4%	10 yr+	1.4×	48%	—	FY2025
52	Demant A/S DEMANT · CO	$9.2B	81/100 卓越	—	21.9%low 13.6%	10 yr+	2.3×	74%	—	FY2025
53	Spirax Group plc SPX · LSE	$6.5B	81/100 卓越	—	20.6%low 13.4%	10 yr+	0.5×	50%	—	FY2025
54	Shanghai Friendess Electronics Tech 688188 · 上海	$5.9B	81/100 卓越	—	27.3%low 11.2%	10 yr+	Net cash	82%	—	FY2025
55	Temenos Group AG TEMN · SW	$5.7B	81/100 卓越	—	36.0%low 19.7%	10 yr+	1.2×	70%	—	FY2025
56	Hisense Kelon Electrical Holdings Co Ltd 000921 · 深圳	$5.3B	81/100 卓越	—	19.1%low 9.4%	10 yr+	Net cash	21%	—	FY2025
57	Lancaster Colony Corporation LANC · 米国株	$4.8B	81/100 卓越	—	17.8%low 10.6%	10 yr+	Net cash	24%	—	FY2024
58	Royal Unibrew A/S RBREW · CO	$3.6B	81/100 卓越	—	29.8%low 19.1%	10 yr+	0.9×	48%	—	FY2025
59	Shanghai Huace Navigation Technology Ltd 300627 · 深圳	$3.2B	81/100 卓越	—	17.0%low 12.2%	10 yr+	Net cash	60%	—	FY2025
60	The Marzetti Company MZTI · 米国株	$2.9B	81/100 卓越	—	17.7%low 10.6%	10 yr+	Net cash	24%	—	FY2025
61	AIMA Technology Group Co Ltd 603529 · 上海	$2.7B	81/100 卓越	—	25.4%low 13.3%	10 yr+	Net cash	15%	—	FY2025
62	Dino Polska SA DNP · WAR	$8.6B	80/100 卓越	—	24.2%low 18.0%	10 yr+	Net cash	24%	—	FY2025
63	Edenred SA EDEN · パリ	$7.3B	80/100 卓越	—	60.0%^‡low 60.0%	10 yr+	—	48%	—	FY2025
64	China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · 深圳	$6.0B	80/100 卓越	—	14.4%low 11.6%	10 yr+	Net cash	60%	—	FY2025
65	Auto Trader Group plc AUTO · LSE	$5.2B	80/100 卓越	—	51.1%low 27.9%	10 yr+	0.5×	91%	—	FY2026
66	Frontdoor Inc FTDR · 米国株	$5.1B	80/100 卓越	—	49.5%low 22.1%	10 yr+	2.7×	47%	—	FY2025
67	Badger Meter Inc BMI · 米国株	$3.9B	80/100 卓越	—	15.1%low 9.2%	10 yr+	Net cash	39%	—	FY2025
68	Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · 深圳	$3.1B	80/100 卓越	—	16.2%low 13.1%	10 yr+	Net cash	66%	—	FY2025
69	Artisan Partners Asset Management Inc APAM · 米国株	$2.8B	80/100 卓越	—	58.6%low 45.9%	10 yr+	0.4×	49%	—	FY2025
70	Pandora A/S PNDORA · CO	$9.4B	79/100 優良	—	56.2%low 26.2%	10 yr+	3.4×	76%	—	FY2025
71	Cirrus Logic Inc CRUS · 米国株	$6.5B	79/100 優良	—	15.6%low 7.9%	10 yr+	Net cash	51%	—	FY2026
72	HEXPOL AB (publ) HPOL-B · ST	$3.3B	79/100 優良	—	17.4%low 13.9%	10 yr+	0.2×	21%	—	FY2025
73	LeMaitre Vascular Inc LMAT · 米国株	$2.3B	79/100 優良	—	12.6%low 7.7%	10 yr+	Net cash	68%	—	FY2025
74	Top Choice Medical Investment Co Inc 600763 · 上海	$2.3B	79/100 優良	—	19.1%low 11.9%	10 yr+	0.2×	42%	—	FY2025
75	Dunelm Group PLC DNLM · LSE	$2.3B	79/100 優良	—	56.5%low 45.8%	10 yr+	2.9×	48%	—	FY2025
76	BeiJing DaHao Technology Co Lt 603025 · 上海	$2.1B	79/100 優良	—	19.2%low 11.8%	10 yr+	Net cash	44%	—	FY2025
77	Installed Building Products Inc IBP · 米国株	$6.0B	78/100 優良	—	31.6%low 19.5%	10 yr+	1.0×	31%	—	FY2025
78	Amdocs Ltd DOX · 米国株	$5.9B	78/100 優良	—	14.3%low 10.3%	10 yr+	0.1×	35%	—	FY2025
79	Softcat plc SCT · LSE	$4.8B	78/100 優良	—	48.1%low 38.0%	10 yr+	Net cash	28%	—	FY2025
80	Imeik Technology Development Co 300896 · 深圳	$4.6B	78/100 優良	—	24.5%low 9.7%	10 yr+	Net cash	92%	—	FY2025
81	China National Medicines Corp Ltd 600511 · 上海	$3.0B	78/100 優良	—	14.8%low 10.8%	10 yr+	Net cash	8%	—	FY2025
82	Alpha Group International plc ALPH · LSE	$2.3B	78/100 優良	—	30.6%low 14.3%	10 yr+	Net cash	78%	—	FY2024
83	Xp Inc XP · 米国株	$8.8B	77/100 優良	—	22.6%low 14.7%	10 yr+	3.2×	67%	—	FY2025
84	Biomerieux SA BIM · パリ	$8.8B	77/100 優良	—	12.8%low 9.5%	10 yr+	Net cash	55%	—	FY2025
85	ExlService Holdings Inc EXLS · 米国株	$5.2B	77/100 優良	—	15.6%low 8.2%	10 yr+	0.1×	36%	—	FY2025
86	Hengan Intl Group Ltd-H 1044 · 香港株	$3.6B	77/100 優良	—	18.0%low 9.9%	10 yr+	0.0×	38%	—	FY2025
87	Jason Furniture(Hangzhou) 603816 · 上海	$2.9B	77/100 優良	—	18.4%low 12.5%	10 yr+	Net cash	34%	—	FY2025
88	Autobio Diagnostics Co Ltd 603658 · 上海	$2.7B	77/100 優良	—	18.8%low 11.5%	10 yr+	Net cash	64%	—	FY2025
89	ePlus inc PLUS · 米国株	$2.4B	77/100 優良	—	13.9%low 11.0%	10 yr+	Net cash	24%	—	FY2026
90	China Resources Double-Crane Pharmaceutical Co Ltd 600062 · 上海	$2.4B	77/100 優良	—	12.3%low 9.4%	10 yr+	Net cash	58%	—	FY2025
91	Hamilton Lane Inc HLNE · 米国株	$6.0B	76/100 優良	—	25.3%low 0.7%	10 yr+	Net cash	67%	—	FY2026
92	Fortune Brands Innovations Inc. FBIN · 米国株	$5.9B	76/100 優良	—	19.9%low 12.5%	10 yr+	1.0×	40%	—	FY2025
93	Hangcha Group Co Ltd 603298 · 上海	$5.2B	76/100 優良	—	16.3%low 12.6%	10 yr+	Net cash	20%	—	FY2025
94	TriNet Group Inc TNET · 米国株	$3.0B	76/100 優良	—	52.5%low 38.4%	10 yr+	12.1×	19%	—	FY2025
95	Joincare Pharmaceutical Group Industry Co Ltd 600380 · 上海	$2.6B	76/100 優良	—	11.5%low 7.3%	10 yr+	Net cash	62%	—	FY2025
96	Neway Valve suzhou Co Ltd 603699 · 上海	$4.9B	75/100 優良	—	17.1%low 8.2%	10 yr+	Net cash	34%	—	FY2025
97	Franklin Electric Co Inc FELE · 米国株	$4.6B	75/100 優良	—	13.7%low 11.1%	10 yr+	0.1×	34%	—	FY2025
98	Kadant Inc KAI · 米国株	$3.6B	75/100 優良	—	13.2%low 9.4%	10 yr+	0.3×	44%	—	FY2025
99	MeiHua Holdings Group Co Ltd 600873 · 上海	$3.2B	75/100 優良	—	17.4%low 10.8%	10 yr+	Net cash	22%	—	FY2025
100	Columbia Sportswear Company COLM · 米国株	$3.0B	75/100 優良	—	12.8%low 5.9%	10 yr+	Net cash	49%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.